Skip to main content
. 2020 Jun 1;17:82. doi: 10.1186/s12978-020-00931-w

Table 2.

Prevalence and absolute average annual change (AAAC) of modern contraceptive (mCPR) use and its subtypes by geography using PMA2020 surveys

Country Year/month Modern contraceptive prevalence Modern contraceptive subtype prevalence
mCPR (95 CI) AAAC (95 CI) SARC (95 CI) LARC (95 CI) PERM (95 CI)
Burkina Faso
 National 2014/11 18.4 (16.3; 20.7) 3.7 (3.0; 4.3) 9.8 (8.3; 11.6) 8.5 (7.0; 10.2) 0.2 (0.0; 0.7)
 National 2015/05 21.0 (18.8; 23.3) 12.3 (10.7; 14.2) 8.8 (7.4; 10.5) 0.1 (0.0; 0.3)
 National 2016/03 25.1 (23.2; 27.1) 13.8 (12.4; 15.4) 12.0 (10.7; 13.6) 0.0 (0.0; 0.1)
 National 2016/12 25.3 (23.4; 27.3) 13.4 (12.0; 14.9) 12.3 (10.9; 13.8) 0.0 (0.0; 0.1)
 National 2017/11 30.9 (28.9; 32.9) 14.8 (13.3; 16.4) 16.2 (14.7; 17.9) 0.1 (0.0; 0.3)
 National 2018/12 31.9 (29.9; 34.0) 17.2 (15.6; 18.8) 14.7 (13.2; 16.3) 0.1 (0.0; 0.3)
Congo DR
 Kinshasa 2013/11 20.3 (18.0; 22.8) 2.6 (2.0; 3.3) 18.2 (16.0; 20.7) 1.6 (1.0; 2.6) 0.4 (0.2; 1.0)
 Kinshasa 2014/09 20.2 (18.4; 22.1) 15.0 (13.5; 16.8) 5.1 (4.2; 6.2) 0.3 (0.1; 0.7)
 Kinshasa 2015/05 22.7 (20.5; 25.0) 17.8 (15.8; 20.0) 4.4 (3.5; 5.7) 0.5 (0.2; 1.1)
 Kinshasa 2015/11 27.1 (25.0; 29.2) 20.5 (18.6; 22.5) 6.1 (5.1; 7.4) 0.6 (0.4; 1.2)
 Kinshasa 2016/09 27.0 (24.5; 29.7) 20.0 (17.8; 22.5) 6.7 (5.3; 8.3) 0.7 (0.3; 1.6)
 Kinshasa 2017/09 28.6 (25.7; 31.7) 19.0 (16.6; 21.7) 9.5 (7.6; 11.8) 0.5 (0.1; 1.6)
 Kinshasa 2018/11 32.8 (30.0; 35.8) 22.5 (20.1; 25.2) 10.1 (8.3; 12.3) 0.5 (0.2; 1.1)
 Kongo Central 2015/12 21.4 (19.2; 23.9) 0.0 (−1.1; 1.1) 18.4 (16.3; 20.7) 1.3 (0.8; 2.1) 2.1 (1.4; 3.0)
 Kongo Central 2016/08 19.3 (17.0; 21.9) 16.3 (14.1; 18.7) 1.8 (1.2; 2.6) 1.3 (0.7; 2.3)
 Kongo Central 2017/09 18.6 (16.3; 21.3) 15.4 (13.3; 17.9) 2.7 (1.8; 3.9) 0.7 (0.3; 1.5)
 Kongo Central 2018/11 22.0 (19.5; 24.8) 17.3 (15.0; 19.9) 4.7 (3.5; 6.2) 0.7 (0.3; 1.5)
Côte d’Ivoire
 National 2017/09 23.7 (21.6; 25.9) −0.9 (−3.8; 2.1) 20.9 (19.0; 23.0) 3.0 (2.2; 4.1) 0.2 (0.1; 0.6)
 National 2018/07 22.8 (20.9; 24.9) 19.7 (17.9; 21.7) 3.3 (2.6; 4.2) 0.0 (0.0; 0.0)
Ethiopia
 National 2014/02 32.7 (30.7; 34.8) 0.9 (0.3; 1.4) 26.9 (25.1; 28.9) 5.8 (5.0; 6.9) 0.1 (0.1; 0.2)
 National 2014/11 34.0 (31.9; 36.1) 26.0 (24.2; 28.0) 7.8 (6.7; 9.1) 0.3 (0.1; 0.8)
 National 2015/04 36.3 (34.6; 38.0) 27.7 (26.1; 29.3) 8.5 (7.6; 9.5) 0.5 (0.3; 0.8)
 National 2016/03 37.7 (35.9; 39.4) 28.4 (26.8; 30.0) 9.8 (8.8; 10.9) 0.3 (0.2; 0.6)
 National 2017/05 35.3 (33.6; 37.1) 25.6 (24.0; 27.1) 9.7 (8.7; 10.8) 0.3 (0.1; 0.6)
 National 2018/06 37.7 (36.0; 39.5) 27.0 (25.4; 28.6) 10.4 (9.4; 11.5) 0.5 (0.3; 0.9)
Ghana
 National 2013/09 17.8 (16.3; 19.5) 2.6 (2.1; 3.1) 14.1 (12.8; 15.6) 3.3 (2.7; 4.2) 0.4 (0.2; 0.8)
 National 2014/03 17.4 (15.9; 19.0) 13.8 (12.5; 15.3) 3.4 (2.7; 4.2) 0.4 (0.2; 0.8)
 National 2014/11 20.2 (18.5; 22.1) 15.6 (14.1; 17.3) 4.1 (3.3; 5.2) 0.6 (0.4; 1.0)
 National 2015/05 27.9 (26.1; 29.9) 21.9 (20.2; 23.7) 5.9 (5.0; 7.0) 0.9 (0.6; 1.4)
 National 2016/09 26.3 (24.3; 28.4) 19.2 (17.4; 21.1) 6.6 (5.6; 7.7) 0.9 (0.5; 1.4)
 National 2017/09 26.1 (24.4; 27.9) 16.9 (15.4; 18.4) 8.5 (7.4; 9.6) 1.3 (0.9; 1.8)
India
 Rajasthan 2016/07 50.7 (49.0; 52.4) 3.6 (2.4; 4.8) 19.6 (18.3; 21.0) 2.0 (1.6; 2.5) 30.8 (29.2; 32.4)
 Rajasthan 2017/03 52.7 (51.1; 54.3) 15.3 (14.2; 16.6) 1.4 (1.0; 1.8) 36.4 (34.9; 38.0)
 Rajasthan 2017/08 55.7 (54.1; 57.3) 17.9 (16.7; 19.2) 1.7 (1.3; 2.1) 36.9 (35.3; 38.4)
 Rajasthan 2018/05 57.9 (56.2; 59.5) 17.5 (16.2; 18.8) 1.9 (1.5; 2.5) 39.1 (37.5; 40.8)
Indonesia
 National 2015/06 59.1 (57.9; 60.4) −0.6 (−2.3; 1.1) 46.8 (45.5; 48.1) 9.1 (8.4; 9.9) 3.7 (3.3; 4.2)
 National 2016/11 58.5 (57.3; 59.8) 45.4 (44.1; 46.6) 9.5 (8.8; 10.3) 3.9 (3.4; 4.4)
Kenya
 National 2014/06 51.8 (49.4; 54.2) 1.2 (0.6; 1.7) 38.3 (36.0; 40.7) 12.2 (10.7; 13.9) 1.9 (1.4; 2.5)
 National 2014/11 53.0 (50.7; 55.2) 38.4 (36.2; 40.6) 12.6 (11.2; 14.2) 3.2 (2.5; 4.1)
 National 2015/06 57.4 (55.2; 59.5) 40.4 (38.2; 42.5) 16.1 (14.5; 17.9) 2.6 (2.0; 3.3)
 National 2015/11 60.9 (58.8; 63.0) 40.3 (38.2; 42.4) 19.6 (17.8; 21.5) 2.8 (2.2; 3.4)
 National 2016/11 58.4 (56.7; 60.0) 37.3 (35.7; 38.9) 20.2 (18.9; 21.7) 2.7 (2.2; 3.4)
 National 2017/11 57.7 (56.0; 59.3) 34.6 (33.0; 36.2) 21.3 (19.9; 22.7) 2.4 (1.9; 3.0)
 National 2018/11 59.2 (57.4; 60.9) 32.8 (31.2; 34.5) 24.5 (23.0; 26.1) 2.4 (1.9; 3.1)
Niger
 National 2016/04 14.7 (12.8; 16.9) 3.1 (0.3; 6.0) 12.4 (10.6; 14.4) 2.1 (1.4; 3.2) 0.2 (0.1; 0.7)
 National 2017/07 18.0 (16.0; 20.1) 14.7 (12.9; 16.7) 3.3 (2.5; 4.3) 0.1 (0.0; 0.4)
 Niamey 2015/07 28.3 (25.3; 31.5) 1.4 (−0.2; 3.0) 22.8 (20.0; 25.7) 5.8 (4.4; 7.6) 0.4 (0.1; 1.3)
 Niamey 2016/11 31.1 (28.1; 34.3) 23.1 (20.4; 26.1) 10.1 (8.2; 12.3) 1.3 (0.8; 2.3)
 Niamey 2018/08 32.5 (29.0; 36.3) 21.6 (18.7; 24.8) 11.3 (8.9; 14.4) 0.1 (0.0; 0.8)
Nigeria
 National 2016/05 17.6 (16.5; 18.7) 1.6 (0.8; 2.4) 14.4 (13.4; 15.4) 3.3 (2.8; 3.9) 0.3 (0.2; 0.5)
 National 2017/04 17.6 (16.5; 18.7) 13.7 (12.7; 14.7) 3.8 (3.3; 4.3) 0.5 (0.3; 0.8)
 National 2018/04 20.9 (19.7; 22.1) 15.6 (14.6; 16.6) 5.2 (4.6; 5.9) 0.5 (0.3; 0.8)
 Kaduna 2014/09 10.0 (8.7; 11.4) 5.4 (2.9; 7.9) 7.8 (6.7; 9.0) 2.1 (1.6; 2.9) 0.1 (0.0; 0.5)
 Kaduna 2015/08 15.3 (13.3; 17.6) 11.6 (9.9; 13.6) 4.5 (3.3; 6.2) 0.7 (0.3; 1.7)
 Lagos 2014/01 18.6 (15.4; 22.2) 7.2 (2.7; 11.7) 17.1 (14.1; 20.6) 1.5 (0.7; 3.1) 0.0
 Lagos 2015/09 25.7 (22.9; 28.7) 20.5 (17.9; 23.3) 4.4 (3.3; 6.0) 0.9 (0.4; 1.9)
Uganda
 National 2014/05 25.4 (23.6; 27.3) 2.4 (1.8; 3.1) 19.9 (18.3; 21.7) 4.1 (3.3; 5.0) 1.8 (1.3; 2.5)
 National 2015/01 31.5 (29.6; 33.6) 23.6 (21.7; 25.5) 5.8 (4.9; 6.9) 2.5 (1.8; 3.3)
 National 2015/09 30.9 (28.9; 32.8) 24.0 (22.2; 25.8) 5.3 (4.5; 6.3) 1.9 (1.4; 2.5)
 National 2016/04 32.2 (30.3; 34.1) 23.9 (22.3; 25.7) 5.7 (4.8; 6.6) 2.8 (2.2; 3.6)
 National 2017/04 34.6 (32.5; 36.7) 24.6 (22.8; 26.6) 7.5 (6.5; 8.8) 2.5 (1.9; 3.3)
 National 2018/04 36.2 (34.1; 38.3) 23.3 (21.5; 25.2) 10.3 (9.1; 11.6) 2.8 (2.1; 3.6)

AAAC absolute average annual change in percentage points, CI: confidence interval, LARC long-acting reversible contraceptive, mCPR modern contraceptive, PERM permanent method, SARC short-acting reversible contraceptive